Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
Search
Close this search box.
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
Menu
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Derivation of Parkinson’s Disease Coded-Stem Cells (PD-SCs)

  • Post author:
  • Post published:May 8, 2025
  • Post category:

Parkinson's disease (PD) is currently the most common neurodegenerative movement disorder, severely debilitating approximately 1-2% of the US population. The disease is caused by a selective loss of dopamine-producing neurons…

Continue ReadingDerivation of Parkinson’s Disease Coded-Stem Cells (PD-SCs)

Generation of clinical grade human iPS cells

  • Post author:
  • Post published:May 8, 2025
  • Post category:

The therapeutic use of stem cells depends on the availability of pluripotent cells that are not limited by technical, ethical or immunological considerations. The goal of this proposal is to…

Continue ReadingGeneration of clinical grade human iPS cells

Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype

  • Post author:
  • Post published:May 8, 2025
  • Post category:

This is an unprecedented time in stem cell biology and regenerative medicine. Today, we have cell lines and tools that did not exist just a few years ago. Indeed, human…

Continue ReadingDerivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype

Derivation of hESC Lines with Disease Lesions

  • Post author:
  • Post published:May 8, 2025
  • Post category:

The inner workings of the nervous system which regulate normal body movements, thought processes, feelings and senses are highly complex. How the nervous system relays and receives this variety of…

Continue ReadingDerivation of hESC Lines with Disease Lesions

Derivation of New ICM-stage hESCs

  • Post author:
  • Post published:May 8, 2025
  • Post category:

Recent studies in the derivation of rodent pluripotent epiblast stem cells and their molecular characterizations have provided strong evidence that the conventional human embryonic stem cells may represent a distinct,…

Continue ReadingDerivation of New ICM-stage hESCs

Derivation of New ICM-stage hESCs

  • Post author:
  • Post published:May 8, 2025
  • Post category:

Recent studies in the derivation of rodent pluripotent epiblast stem cells and their molecular characterizations have provided strong evidence that the conventional human embryonic stem cells may represent a distinct,…

Continue ReadingDerivation of New ICM-stage hESCs

Induced Pluripotent Stem Cells for Cardiovascular Diagnostics

  • Post author:
  • Post published:May 8, 2025
  • Post category:

Our objective is to use induced pluripotent stem (iPS) cell technology to produce a cell-based test for long QT syndrome (LQTS), a major form of sudden cardiac death. Nearly 500,000…

Continue ReadingInduced Pluripotent Stem Cells for Cardiovascular Diagnostics

Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses

  • Post author:
  • Post published:May 8, 2025
  • Post category:

Embryonic stem cells open up exciting new prospects for medicine, because they can differentiate into any tissue in the body. Therefore, they have the potential to be used to repair…

Continue ReadingSafe, efficient creation of human induced pluripotent stem cells without the use of retroviruses

Optimization of Human Embryonic Stem Cell Derivation Techniques and Production/Distribution of GMP-Grade Lines

  • Post author:
  • Post published:May 8, 2025
  • Post category:

The government has strict rules for producing cells that will be transplanted into patients. For example, these regulations discourage the use of animal products that could transmit diseases to humans.…

Continue ReadingOptimization of Human Embryonic Stem Cell Derivation Techniques and Production/Distribution of GMP-Grade Lines

Induction of pluripotent stem cells by small RNA-guided transcriptional activation

  • Post author:
  • Post published:May 8, 2025
  • Post category:

Embryonic stem cells have great potential in therapeutic use to replace diseased or damaged tissues because they have the unique capability of giving rise to any cell type of the…

Continue ReadingInduction of pluripotent stem cells by small RNA-guided transcriptional activation
  • Go to the previous page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Multimedia Resources
  • Contact Us